Tenet Q3 net income $131M, adj EPS $1.44; announces $1B buyback; FY22 EBITDA outlook narrowed

TENET HEALTHCARE CORP

2022-Q3 EPS reported $2.82 revenue$14,184,000,000

Q3 net income from continuing ops $131M ($1.16 diluted EPS); adjusted diluted EPS $1.44.
Consolidated Adj. EBITDA $841M vs $855M in Q3 2021; USPI (ambulatory) EBITDA up 16.4% to $319M.
Board authorized $1B share repurchase program expiring Dec 31, 2024.
FY2022 Adj. EBITDA outlook revised to $3.375-$3.475B, ~1% change at midpoint.
Repaid $880M Medicare advances; free cash flow $190M in 9 months (excl. advances $1.07B).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.